Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release. [electronic resource]
- Cytokine Jul 2009
- 11-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0023
10.1016/j.cyto.2009.03.004 doi
Animals Antibodies, Monoclonal--immunology Apoptosis--drug effects Cell Hypoxia--drug effects Cell Line Cell Survival--drug effects Gene Expression--physiology Hepatocytes--cytology Hyaluronan Receptors--metabolism L-Lactate Dehydrogenase--metabolism Matrix Metalloproteinase 9--metabolism Nitroimidazoles--metabolism Phosphorylation--drug effects Proliferating Cell Nuclear Antigen--metabolism Protein Serine-Threonine Kinases--metabolism Rats Rats, Sprague-Dawley Receptor, Transforming Growth Factor-beta Type I Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta--metabolism Serum--physiology Smad2 Protein--metabolism Transforming Growth Factor beta1--genetics